Skip to main content
A-Alpha BioAB

A-Alpha Bio

A-Alpha Bio is a biotechnology company committed to leveraging synthetic biology and machine learning for drug development through innovative measurement of protein interactions.

About A-Alpha Bio

A-Alpha Bio is a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Founded in 2017 at the University of Washington's Institute for Protein Design and Center for Synthetic Biology, A-Alpha Bio has distinguished itself in the biopharmaceutical landscape by developing innovative technologies aimed at improving drug discovery processes. The company's proprietary platform, AlphaSeq, allows the rapid and quantitative measurement of millions of protein-protein binding affinities simultaneously. With this capability, A-Alpha Bio generates high-resolution interaction data necessary for accelerating therapeutic discovery and addressing unmet medical needs in various disease areas, including cancer, infectious diseases, and neurological disorders.

In addition to its experimental capabilities, A-Alpha Bio employs computational advancements through its AlphaBind platform, which predicts protein binding strength based on sequence data. By leveraging extensive datasets, the company facilitates the design and optimization of biologics and therapeutics. A-Alpha Bio partners with leading pharmaceutical companies to enhance therapeutic development pipelines, focusing on critical applications such as antibody discovery and molecular glue technology. Through the integration of cutting-edge techniques and a unique approach to data generation, A-Alpha Bio is on a mission to improve human health by pioneering advances in biotechnology.

FAQs

Which countries does A-Alpha Bio have remote employees in?
A-Alpha Bio has employees in United States.
When was A-Alpha Bio founded?
A-Alpha Bio was founded in 2017.
Who is the CEO of A-Alpha Bio?
The CEOs of A-Alpha Bio are David Younger, PhD.
How many employees does A-Alpha Bio have?
A-Alpha Bio has 51-200 employees.
What industries or markets does A-Alpha Bio operate in?
A-Alpha Bio operates in the following markets: Synthetic Biology, Machine Learning, Drug Discovery, Protein Engineering, Therapeutics Development, Cancer Research, Infectious Disease Research, Neurological Disorder Research, Pharmaceutical, and Biotech.
What is A-Alpha Bio's website?
A-Alpha Bio's website is aalphabio.com.
Where can I find A-Alpha Bio on social media?
You can find A-Alpha Bio on LinkedIn.
Claim this profileA-Alpha Bio logoAB

A-Alpha Bio

Company size

51-200 employees

Founded in

2017

Chief executive officer

David Younger, PhD

Markets

Employees live in

Visit aalphabio.com

Remote companies like A-Alpha Bio

Find your next opportunity by exploring profiles of companies that are similar to A-Alpha Bio. Compare culture, benefits, and job openings on Himalayas.

View all companies

Get matched with your dream remote job

Sign up now and join over 1,000,000+ remote workers who receive personalized job alerts, curated job matches, and more for free!

Sign up
A-Alpha Bio | Himalayas